JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Progression of NETs Correlating with Tumor-Related Diseases
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Progression of NETs Correlating with Tumor-Related Diseases
Zhang, Le-Meng; Chen, Jian-Hua;
  PDF(new window)
 Abstract
As an important component of innate immune system, neutrophil has been involved in many other physiological processes, including tumor-related diseases. In 2004, the phenomenon of NETs was reported for the first time. Extracellular decondensed chromatin, released from activated neutrophils, forms a network structure, which is NETs. This review focuses on the function of NETs in tumor cell proliferation, metastasis, and tumor-associated thrombosis; it also explores the application of NETs specific markers in the diagnosis of pre-thrombotic state and tumor associated diseases; it also explores NETs inhibitor for the treatment of tumor-related diseases. In view of the rapid development of NETs, it may provide new therapeutic targets for tumor-associated thrombosis, and even tumor itself.
 Keywords
Neutrophil extracellular traps;tumor-related diseases;thrombosis;citrullinated histone;
 Language
English
 Cited by
 References
1.
Ammollo CT, Semeraro F, Xu J, et al (2011). Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost, 9, 1795-803. crossref(new window)

2.
Amulic B, Cazalet C, Hayes GL, et al (2012). Neutrophil function: from mechanisms to disease. Annu Rev Immunol, 30, 459-89. crossref(new window)

3.
Berger-Achituv S, Brinkmann V, Abed UA, et al (2013). A proposed role for neutrophil extracellular traps in cancer immunoediting. Front Immunol, 4, 48.

4.
Bergers G, Brekken R, McMahon G, et al (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol, 2, 737-744. crossref(new window)

5.
Borissoff JI, Joosen IA, Versteylen MO, et al (2013). Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol, 33, 2032-40. crossref(new window)

6.
Brandau S, Dumitru CA, Lang S (2013). Protumor and antitumor functions of neutrophil granulocytes. Semin Immunopathol, 35, 163-76. crossref(new window)

7.
Brinkmann V, Reichard U, Goosmann C, et al (2004). Neutrophil extracellular traps kill bacteria. Science, 303, 1532-5. crossref(new window)

8.
Chang X, Han J (2006). Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors. Mol Carcinog, 45, 183-96. crossref(new window)

9.
Chang X, Han J, Pang L, et al (2009). Increased PADI4 expression in blood and tissues of patients with malignant tumors. Bmc Cancer, 9, 40. crossref(new window)

10.
Clark SR, Ma AC, Tavener SA, et al (2007). Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med, 13, 463-9. crossref(new window)

11.
Cools-Lartigue J, Spicer J, McDonald B, et al (2013). Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest.

12.
Cools-Lartigue J, Spicer J, Najmeh S, et al (2014). Neutrophil extracellular traps in cancer progression. Cell Mol Life Sci, 71, 4179-94. crossref(new window)

13.
Darrah E, Andrade F (2012). NETs: the missing link between cell death and systemic autoimmune diseases? Front Immunol, 3, 428.

14.
Demers M, Krause DS, Schatzberg D, et al (2012). Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A, 109, 13076-81. crossref(new window)

15.
Demers M, Wagner DD (2013). Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunol, 2, 22946. crossref(new window)

16.
Demers M, Wagner DD (2014). NETosis: a new factor in tumor progression and cancer-associated thrombosis. Semin Thromb Hemost, 40, 277-83. crossref(new window)

17.
Fuchs TA, Abed U, Goosmann C, et al (2007). Novel cell death program leads to neutrophil extracellular traps. J Cell Biol, 176, 231-41. crossref(new window)

18.
Fuchs TA, Kremer HJ, Schatzberg D, et al (2012). Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood, 120, 1157-64. crossref(new window)

19.
Goldhaber SZ, Tapson VF (2004). A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol, 93, 259-62. crossref(new window)

20.
Gregory AD, Houghton AM (2011). Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res, 71, 2411-6. crossref(new window)

21.
Houghton AM, Rzymkiewicz DM, Ji H, et al (2010). Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med, 16, 219-23. crossref(new window)

22.
Huh SJ, Liang S, Sharma A, et al (2010). Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res, 70, 6071-82. crossref(new window)

23.
Kannemeier C, Shibamiya A, Nakazawa F, et al (2007). Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A, 104, 6388-93. crossref(new window)

24.
Kessenbrock K, Krumbholz M, Schonermarck U, et al (2009). Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med, 15, 623-5. crossref(new window)

25.
Leshner M, Wang S, Lewis C, et al (2012). PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Front Immunol, 3, 307.

26.
Li P, Li M, Lindberg MR, et al (2010). PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med, 207, 1853-62. crossref(new window)

27.
Li P, Wang D, Yao H, et al (2010). Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression. Oncogene, 29, 3153-62. crossref(new window)

28.
Li P, Yao H, Zhang Z, et al (2008). Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol, 28, 4745-58. crossref(new window)

29.
Longstaff C, Varju I, Sotonyi P, et al (2013). Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones. J Biol Chem, 288, 6946-56. crossref(new window)

30.
Makino H, Kunisaki C, Kosaka T, et al (2011). Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer. Br J Surg, 98, 975-82. crossref(new window)

31.
Manfredi AA, Rovere-Querini P, Maugeri N (2010). Dangerous connections: neutrophils and the phagocytic clearance of activated platelets. Curr Opin Hematol, 17, 3-8. crossref(new window)

32.
Mantovani A (2009). The yin-yang of tumor-associated neutrophils. Cancer Cell, 16, 173-4. crossref(new window)

33.
Martinod K, Demers M, Fuchs TA, et al (2013). Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc Natl Acad Sci U S A, 110, 8674-9. crossref(new window)

34.
Massberg S, Grahl L, von Bruehl ML, et al (2010). Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med, 16, 887-96. crossref(new window)

35.
Masson V, de la Ballina LR, Munaut C, et al (2005). Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. Faseb J, 19, 234-6.

36.
Metzler KD, Fuchs TA, Nauseef WM, et al (2011). Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood, 117, 953-9. crossref(new window)

37.
Nakazawa D, Tomaru U, Yamamoto C, et al (2012). Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis. Front Immunol, 3, 333.

38.
Palmer LJ, Cooper PR, Ling MR, et al (2012). Hypochlorous acid regulates neutrophil extracellular trap release in humans. Clin Exp Immunol, 167, 261-8. crossref(new window)

39.
Papayannopoulos V, Metzler KD, Hakkim A, et al (2010). Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol, 191, 677-91. crossref(new window)

40.
Sorensen HT, Mellemkjaer L, Olsen JH, et al (2000). Prognosis of cancers associated with venous thromboembolism. N Engl J Med, 343, 1846-50. crossref(new window)

41.
Spicer JD, McDonald B, Cools-Lartigue JJ, et al (2012). Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. Cancer Res, 72, 3919-27. crossref(new window)

42.
Wang Y, Li M, Stadler S, et al (2009). Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol, 184, 205-13. crossref(new window)

43.
Wilson TJ, Nannuru KC, Futakuchi M, et al (2010). Cathepsin G-mediated enhanced TGF-beta signaling promotes angiogenesis via upregulation of VEGF and MCP-1. Cancer Lett, 288, 162-9. crossref(new window)

44.
Xu J, Zhang X, Pelayo R, et al (2009). Extracellular histones are major mediators of death in sepsis. Nat Med, 15, 1318-21. crossref(new window)